A Face Cream Made with Your Own Blood: Autologous Regenerative Skincare Explained
By Dr Muhammad Nadim (M.Biomed) · Updated 30 September 2026
An autologous face cream combines a formulated skincare base with a specified preparation derived from the same patient's blood. It is a patient-specific topical product, not raw blood, a conventional injectable treatment or a cream made entirely from living cells.
SŌMA Longevity Club, Uluwatu, Bali, is the only clinic in Bali offering personalised regenerative topical care prepared from patients' own blood, and it is part of our expanding autologous protocols. Before a patient takes it home, its role should be clear: what it contains, where it belongs in the skincare plan, and how it must be handled.
What is actually inside the cream?
There are two parts. The first is the cream base, which gives the product its texture and includes the ingredients needed for the formulation. The second is the autologous fraction, prepared from the patient's own blood according to the clinical protocol.
Published technical preparation information describes blending a cream base with CGF- and PRP-derived material. That establishes the concept of the product, but does not mean every personalised cream has the same composition.
The full ingredient list of the base matters. Patients should be able to review it before use, especially when they have a history of contact allergy. There is no reason to assume that hyaluronic acid, vitamins, botanical extracts or particular preservatives are present unless the actual label lists them.
What are the biological ingredients intended to do?
Blood-derived preparations can contain plasma proteins and platelet-associated signalling factors. In research, factors such as PDGF and TGF-β are studied for their involvement in tissue responses and repair. Their presence is a biological rationale for investigation, not a measured promise of what a jar will achieve.
For example, laboratory research on plasma fractions detected differences in TGF-β activity between preparations. Processing changed that activity. The important lesson is that preparation matters; simply adding the words growth factors to a product description does not establish its final potency.
A personalised cream should not be advertised as containing a guaranteed number of active exosomes or living stem cells without appropriate testing. Nor should a patient's own blood be treated as an ingredient whose composition is identical every time.
What benefits are supported by research?
The direct clinical evidence is preliminary. A 2019 pilot study by Draelos and colleagues enrolled 20 adults in a split-face, vehicle-controlled study. A specific PRP-containing topical formulation was used after electroporation for eight weeks. The researchers reported histological and collagen-related changes. The study had commercial funding and was not a trial of SŌMA's cream.
These findings justify further investigation. They do not establish that an autologous cream reliably removes wrinkles, treats scars or works better than conventional skincare. Because the study included electroporation, its results cannot simply be transferred to ordinary application on intact skin.
For patients, it is useful to separate the moisturising or cosmetic role of the base from the proposed additional effect of the blood-derived fraction. The latter is the part that needs more product-specific clinical evidence.
Where might it fit into a skincare plan?
A personalised cream may be discussed when a patient is exploring an individual topical routine alongside clinic-based skin care. The goals might involve skin comfort or appearance, but the recommendation should account for the base formulation and the patient's existing routine.
It is not a stand-alone treatment for active acne, rosacea, eczema, an infected wound or a suspicious skin lesion. Those concerns need an appropriate diagnosis and their own treatment plan. It does not replace sunscreen or automatically replace a prescribed medicine.
After a procedure, the timing is particularly important. A product suitable for intact skin is not automatically suitable for a fresh incision, an open wound or recently treated skin. Do not apply it immediately after laser treatment or microneedling unless the treating clinician has explicitly cleared the exact product and timing.
How should an autologous cream be applied?
Your patient label and written instructions take priority over a general article. A published technical protocol describes a thin application to clean skin, twice daily, using a disposable spatula; that schedule should be used only when it matches the formulation and instructions supplied to you.
For a prescribed take-home routine, use the following handling principles:
Check the patient name, preparation date, expiry and storage directions before the first application.
Wash and dry your hands, then cleanse the intended area as instructed.
Remove the prescribed amount using the supplied dispensing method or a fresh disposable spatula. Do not return unused cream to the container.
Apply only to the areas and at the frequency specified. More cream is not evidence of more benefit.
Close the container promptly and return it to the required storage conditions.
Ask how it should fit with sunscreen, retinoids, exfoliating acids and prescribed topicals. Do not invent a layering schedule or add products to the jar. General FDA advice on cosmetic contamination reinforces the importance of clean handling, suitable storage and not diluting or sharing products.
Does it need refrigeration, and how long does it last?
Storage and expiry must be assigned to the final formulation, not borrowed from a different product. They depend on the mixture, preservative system, packaging and supporting stability and microbiological information.
Historical technical guidance for one autologous cream formulation specifies refrigeration at 4–8°C and approximately one month of use. That is not a universal shelf life, and it should not be read as microbiological validation of another base or container.
Follow the temperature range and discard date on your SŌMA label. Do not use a jar with missing instructions. Do not freeze it unless the specific instructions permit freezing. Refrigeration does not make a contaminated product safe again.
If the product has been left outside its required storage range, contact the clinic before further use. Do not rely on smell or appearance alone to decide that it is still suitable.
What should travellers in Bali consider?
Discuss storage before the cream is prepared. A hotel minibar should not be assumed to maintain the specified temperature. Transfers, flights and time away from refrigeration also need a practical plan.
The clinic should explain transport arrangements and whether a take-home preparation is appropriate for the journey. Entry rules in the destination country are a separate question from airline liquid allowances. It may be more sensible to choose another aftercare option than accept a product that cannot be stored as directed.
When is it not a good choice?
Do not use the cream when you are known to be allergic to an ingredient, the container has lost its integrity, the expiry has passed or the required storage history is uncertain. Do not share it with a partner or family member.
An active skin infection, broken skin or a recent procedure calls for clinical review rather than self-application. People with significant immune suppression, pregnancy or breastfeeding should discuss suitability because evidence for elective autologous topical products in these situations is limited. An autologous origin is not a substitute for that assessment.
Stop using the product and contact the clinic if it causes persistent burning, increasing redness, swelling, a rash or signs of infection. Severe symptoms require prompt medical assessment.
Is the personalised mask the same thing?
No. A mask has its own base, application time and intended setting. A take-home cream has a separate routine and storage requirements. Neither should be used as an injection or transferred into a home microneedling routine.
The treatment team should explain which product is being offered and whether it is intended for a single in-clinic application or use at home.
Frequently asked questions
Is it really made from my blood?
It contains a specified fraction prepared from your blood, mixed with a formulated base. It is not simply whole blood, and it is not entirely autologous material.
Does it contain the same ingredients as PRP injections?
Not necessarily. The selected fraction and final formulation differ, and applying a product to the skin is not equivalent to injecting it.
Can I mix my own PRP with moisturiser?
No. A home mixture has no established formulation, compatibility, preservation or expiry. Preparation belongs within a supported clinical process, not a DIY skincare recipe.
Can it remove acne scars or replace a filler?
There is not adequate evidence to promise either. A cream does not have the same role as scar-directed procedures or a volume treatment.
Personalised care should come with clear instructions
At SOMA, the conversation about an autologous cream should cover both its intended role and the practical details of using it. Contact the clinic to ask about suitability, ingredients and aftercare before arranging a personalised preparation.
This is general patient information. The approved formulation, clinical assessment and instructions supplied with the actual product govern its use.
